Michael Thomas Ropacki
Corporate Officer/Principal at ORYZON GENOMICS S.A.
Profile
Michael Thomas Ropacki is currently the Chief Medical Officer-CNS at Oryzon Genomics SA and the President at Strategic Global Research & Development.
Previously, he worked as the Director-Clinical Development & Neuroscience at Janssen Research & Development LLC from 2013 to 2016, the Head-Global Medical Affairs at Janssen Alzheimer Immunotherapy from 2011 to 2013, and the Senior Vice President-Clinical Development at MedAvante-ProPhase, Inc. in 2017.
He holds a doctorate degree from Texas Tech University.
Michael Thomas Ropacki active positions
Companies | Position | Start |
---|---|---|
ORYZON GENOMICS S.A. | Corporate Officer/Principal | 01/02/2021 |
Strategic Global Research & Development | President | - |
Former positions of Michael Thomas Ropacki
Companies | Position | End |
---|---|---|
MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | 01/10/2017 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Chief Tech/Sci/R&D Officer | 01/02/2016 |
Janssen Alzheimer Immunotherapy | Chief Tech/Sci/R&D Officer | 01/05/2013 |
Training of Michael Thomas Ropacki
Texas Tech University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Private companies | 4 |
---|---|
Janssen Alzheimer Immunotherapy | |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
MedAvante-ProPhase, Inc. | |
Strategic Global Research & Development |
- Stock Market
- Insiders
- Michael Thomas Ropacki